Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
Clinical trial NCT07301008 · RECRUITING
Trial details
- NCT number
- NCT07301008
- Sponsor
- Medstar Health Research Institute
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-09
- Primary completion
- 2026-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.